Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin
- DOI
- 10.1007/s11523-026-01253-w
- Published
- 2026-09-16
- Container
- Targeted Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11523-026-01253-w,
title = {Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin},
author = {Wendy Stock and Ryan D. Cassaday and Daniel J. DeAngelo and Anjali Advani and Nicola Gokbuget and Josep Ribera and Wei Jiang and Susana Pulido and Erik Vandendries and Nathan Braniff and Elias Jabbour and Hagop Kantarjian},
year = {2026},
journal = {Targeted Oncology},
doi = {10.1007/s11523-026-01253-w},
url = {https://doi.org/10.1007/s11523-026-01253-w}
}RIS
TY - JOUR TI - Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin AU - Wendy Stock AU - Ryan D. Cassaday AU - Daniel J. DeAngelo AU - Anjali Advani AU - Nicola Gokbuget AU - Josep Ribera AU - Wei Jiang AU - Susana Pulido AU - Erik Vandendries AU - Nathan Braniff AU - Elias Jabbour AU - Hagop Kantarjian PY - 2026 JO - Targeted Oncology DO - 10.1007/s11523-026-01253-w UR - https://doi.org/10.1007/s11523-026-01253-w ER -
APA
Stock, W., Cassaday, R. D., DeAngelo, D. J., Advani, A., Gokbuget, N., Ribera, J., Jiang, W., Pulido, S., Vandendries, E., Braniff, N., Jabbour, E., & Kantarjian, H. (2026). Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin. Targeted Oncology. https://doi.org/10.1007/s11523-026-01253-w
Source records
- crossref · retrieved 2026-09-27T15:56:23.393Z